亚洲 · 新闻 · The Korea Herald

Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?

来源：The Korea Herald · 韩国 16 小时前

Hanmi Pharmaceutical’s Eppe is poised to challenge Wegovy and Mounjaro in Korea’s fast-growing obesity drug market, with price emerging as a potentially decisiv ...

在 The Korea Herald 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.koreaherald.com)

Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?

推荐阅读

Delinquent health insurance premiums owed by foreigners total 37.5 bln won

Kai Tak Hospital starts first phase of operations, treats 300 patients on day 1

Honda plans highway test of wireless charging for moving trucks

Ayala Corporation's Notice of Special Stockholders’ Meeting 1/2

U.S. accuses California woman of spying for China, surveilling Taiwan leader’s son

Japan remains 12th in global innovation ranking, trails South Korea, China

Korea’s first homegrown GLP-1: Can Hanmi’s Eppe undercut Mounjaro and Wegovy?

分享

推荐阅读

Delinquent health insurance premiums owed by foreigners total 37.5 bln won

Kai Tak Hospital starts first phase of operations, treats 300 patients on day 1

Honda plans highway test of wireless charging for moving trucks

Ayala Corporation's Notice of Special Stockholders’ Meeting 1/2

U.S. accuses California woman of spying for China, surveilling Taiwan leader’s son

Japan remains 12th in global innovation ranking, trails South Korea, China